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Uropathogenic Escherichia coli (UPEC) is the predominant cause of urinary tract infection in both hospital and community set-
tings. The recent emergence of multidrug-resistant clones like the O25b:H4-ST131 lineage represents a significant threat to
health, and numerous studies have explored the virulence potential of these organisms. Members of the ST131 clone have been
described as having variable carriage of key virulence factors, and it has been suggested that additional unidentified factors con-
tribute to virulence. Here we demonstrated that ST131 isolates have high metabolic potential and biochemical profiles that dis-
tinguish them from isolates of many other sequence types (STs). A collection of 300 UPEC isolates recovered in 2007 and 2009 in
the Northwest region of England were subjected to metabolic profiling using the Vitek2 Advanced Expert System (AES). Of the
47 tests carried out, 30 gave a positive result with at least one of the 300 isolates examined. ST131 isolates demonstrated signifi-
cant association with eight tests, including those for peptidase, decarboxylase, and alkalinization activity. Metabolic activity also
correlated with antibiotic susceptibility profiles, with resistant organisms displaying the highest metabolic potential. This is the
first comprehensive study of metabolic potential in the ST131 lineage, and we suggest that high metabolic potential may have
contributed to the fitness of members of the ST131 clone, which are able to exploit the available nutrients in both the intestinal
and urinary tract environments.
Escherichia coli is a very diverse member of the normal intestinalflora of humans and other mammals. Some E. coli bacteria are
considered uropathogenic (UPEC), and this subset differs sub-
stantially from the majority of enteric E. coli in terms of virulence
profiles, phylogenetic grouping, and serotype (31).
Urinary tract infection (UTI) usually occurs following the
movement of UPEC from the intestinal tract to the periurethral
area (13). In a study of urovirulence characteristics of fecal E. coli,
it was demonstrated that the phylogenetic groups B2 and D, which
are strongly associated with UPEC, tend to dominate, leading to
low clonal diversity, suggesting the presence of unknown bacterial
factors that contribute to fitness within the intestine prior to
transfer to the urinary tract (20).
Generally, the ability of UPEC to colonize and cause infection
in the urinary tract results from the cumulative action of specific
virulence factors (VFs). These include determinants that aid resis-
tance to host defenses, mediate adhesion, increase iron acquisi-
tion, or paralyze ureteric peristalsis (10); however, these VFs are
not sufficient to explain the success of UPEC clones like ST131
(14, 21), which shows moderate VF profiles compared to other
successful sequence types (STs), such as ST69 and ST127 (8). It has
recently been suggested that bacterial metabolic capability en-
hances fitness and contributes to pathogenesis, which could pro-
vide an alternative explanation for the success of prevalent UPEC
clones (16), and previous reports have shown that certain meta-
bolic enzymes may also enhance virulence (22). For example, the
ability of UPEC to catabolize the amino acid D-serine during UTI
supports bacterial growth and acts as a signaling mechanism to
trigger virulence gene expression (2, 24).
Biotyping, like most phenotypic methods, is considered to be
an unreliable epidemiological tool because of its modest repro-
ducibility and poor discriminatory power, though this depends
greatly on the pathogen in question. Indeed, E. coli strains can
have considerable biochemical variability (9), and biotyping can
be a dependable method for their characterization (3, 12, 17).
Recent advances in automated biotyping methods provide
more reliable tools that rely on a variety of novel substrates and
precise interpretation techniques that increase reproducibility
and discriminatory power (27). In this study, we examined the
metabolic potential of UPEC and demonstrated an association
between members of the ST131 clone and certain metabolic pro-
files.
MATERIALS AND METHODS
Bacterial strains. 300 UPEC isolates were included in this study, 150
isolates being collected in June 2007 and 150 in June 2009. Isolates were
recovered from nonduplicate, consecutive urine samples received by the
microbiology laboratories at hospitals in Manchester (200 isolates) and
Preston (100 isolates), United Kingdom. The multilocus sequence typing
(MLST) of isolates and identification of virulence capacity and antibiotic
susceptibility profiles have been previously described (8).
Metabolic profiling. The Vitek 2 compact Automated Expert Sys-
tem (AES) (bioMérieux) was used for metabolic profiling. Using the
Vitek 2 ID-GNB card (bioMérieux), identification of Gram-negative
bacilli occurs through testing the organism’s metabolic activity in 47
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biochemical tests designed to measure carbon source utilization and
enzymatic activity.
Correlation analyses. The metabolic profiles of the isolates were com-
pared in a pairwise fashion, and the similarity matrix obtained was clus-
tered according to the unweighted pair group method using average link-
ages (UPGMA). Associations between different parameters were analyzed
by using Fisher’s exact or Mann-Whitney U tests, and the threshold for
statistical significance was a P value of 0.05. Where appropriate, more
stringent criteria for statistical significance were used.
Aggregate scores for metabolic activities (Bio) and antimicrobial re-
sistance (AST) were calculated for each isolate as the sum of all parameters
for which the isolates tested positive divided by the total number of pa-
rameters tested. Correlation analysis between Bio and AST scores were
analyzed using Pearson’s correlation coefficients. Correlation analysis was
also used to describe the association of different STs with the aggregate
scores calculated for metabolic activities and the resistance to different
antimicrobial drugs.
RESULTS
Although the MLST data relating to the isolate collection have
been previously described, a summary is given here. Among the
100 STs identified, 9 (ST73, ST131, ST69, ST95, ST10, ST127,
ST14, ST88, and ST405) accounted for 59% of the collection (50,
37, 27, 19, 13, 11, 8, 6, and 5 isolates, respectively). Of the 37 ST131
isolates identified, 11 belonged to the O25b-CTX-M-15 subclone,
all of which been characterized as multidrug resistant (resistant to
at least three antibiotic groups), and the remaining 26 were non-
O25b-CTX-M-15 ST131, of which only seven were considered
multidrug resistant (8).
ST131 UPEC demonstrate higher metabolic capabilities than
those of other STs. Of the 47 tests employed by the Vitek AES, 30
gave a positive result with at least 1 of the 300 isolates examined.
These tests were included in the following analyses for differenti-
ation between UPEC isolates (Table 1). Tests that were found to be
negative for all strains tested are shown in Table S1 in the supple-
mental material.
To assess whether isolates of certain STs share specific meta-
bolic characteristics, two analytical approaches were used. First, a
nonparametric comparison analysis using the Mann-Whitney U
test was used to compare the aggregate Bio scores generated for
each ST against all others. Isolates of ST131were significantly
more likely to have a higher Bio score than isolates of all other STs
(P  0.0001), and ST127 isolates showed a significant association
with low Bio scores (P  0.003) (Table 2).
Second, the statistical association of activity in individual met-
abolic tests with STs was assessed using Fisher’s exact test. Of the
30 metabolic activities tested, isolates of common STs were signif-
icantly associated with 11 tests. Remarkably, ST131 exhibited sig-
nificant associations (six positive and two negative) with eight
tests, indicating distinctive biochemical characteristics (Table 3),
and ST73 had a significant association with four tests. In contrast,
isolates of ST14 and ST405 showed no difference in their meta-
bolic activity compared to the rest of the tested isolates.
In ST131, metabolic potential is correlated with antibiotic
susceptibility. UPGMA cluster analysis based on the biochemical
profiles of isolates from the major STs revealed a large cluster
comprised almost entirely of ST131 (19/21 cluster members) and
included 51% of the total ST131 isolates (Fig. 1). The cluster was
defined at the 70% similarity level and contained isolates previ-
ously identified as being resistant to multiple antibiotics (8). The
remaining ST131 isolates were found scattered through the den-
drogram. Although there was a tendency for isolates with the same
ST to cluster together, only ST73 and ST69 gathered in clusters
consisting primarily of their respective STs. Other than ST131, no
correlation was found between the defined clusters and antibiotic
resistance profiles (Fig. 1).
No significant correlation was observed when Pearson’s corre-
lation coefficient was determined between Bio and AST scores
(r2  0.1476). However, the comparison revealed an appreciable
correlation coefficient that justified further investigation.
Subsequent examination of the correlations at the level of each
ST revealed a weak but significant positive association between
Bio and AST scores (P  0.01) among ST131 isolates, which could
explain the correlation observed between Bio and AST scores in
the general population (Table 4).

































TABLE 2 Aggregate Bio scores in relation to STs
ST Median (range) aggregate Bio score P valuea
ST10 0.55 (0.48–0.65) 0.670
ST14 0.59 (0.55–0.72) 0.145
ST69 0.55 (0.48–0.72) 0.967
ST73 0.59 (0.45–0.65) 0.770
ST88 0.52 (0.51–0.58) 0.216
ST95 0.55 (0.45–0.62) 0.973
ST127 0.52 (0.45–0.55) 0.003
ST131 0.62 (0.48–0.76) 0.0001
ST405 0.55 (0.41–0.69) 0.771
a P values (Mann-Whitney U test) show the significance of the different Bio scores of
each ST compared to the other STs. Bold indicates a significant result.
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Cluster analysis of a simple matching coefficient based on the
metabolic profiles was used to generate a dendrogram describing
the association of ST131 and antibiogram profiles. This revealed a
large ST131 cluster defined at the 88% similarity level and com-
prised of 22 (60%) isolates that were characterized as having a
multiple resistance antibiogram (Fig. 2).
A nine-digit numerical code (three tests per digit) was gener-
ated using the results of 27 biochemical tests (3 tests being positive
for all isolates) to yield the Bio score, with a high score indicating
increased metabolic potential. A total of 149 different profiles
were detected, of which 19 were solely associated with ST131 iso-
lates. Figure 3 shows the distribution of isolates on the basis of
biochemical profiles. Interestingly, isolates of ST131 were divided
into 2 groups, susceptible and multidrug resistant, where multi-
drug-resistant isolates and those of CTX-M-15 O25b were signif-
icantly associated with high Bio scores.
To investigate whether the observed distinctive characteristics
of ST131 are general characteristics of the clone or are only the
result of O25b-CTX-M-15 ST131 clonal spread, a comparative
analysis of incidence of these characteristics in O25b-CTX-M-15
ST131 and non-O25b-CTX-M-15 ST131 isolates compared with
non-ST131 isolates was carried out. Although numbers of repre-
sentative strains are small in some cases and most of the charac-
teristics are general features of the ST131 clone, some biochemical
traits were significantly associated with O25b-CTX-M-15 ST131,
FIG 1 UPGMA cluster analysis based on the biochemical profiles of major
sequence types.
TABLE 3 Statistical analysis of association between STs and individual metabolic testsa
ST
P value for biochemical testb
ADO AGAL BGUR ILATa ILATk 5KG ODC O129R PHOS ProA SAC
ST10 0.0012 0.0001
ST14
ST69 0.0017 0.0001 0.0001




ST131 0.0041 0.0002 0.0017 0.0041 0.0001 0.0034 0.0001 0.0001
ST405
a P values (by Fisher’s exact test) were calculated for each ST compared to the rest of the population, shown only where P  0.005. Bold P values indicate negative associations. For
abbreviations, see Table 1.
b No. (%) of positive isolates is as follows: for ADO, 6 (2); for AGAL, 208 (69); for BGUR, 275 (92); for ILATa, 3 (1); for ILATk, 120 (40); for 5KG, 123 (41); for ODC, 227 (76); for
O129R, 175 (58); for PHOS, 36 (12); for ProA, 28 (9); for SAC, 167 (56).




(r2), Bio vs. AST





ST10 0.0000 O O
ST14 0.1123 O O
ST69 0.0041 O O
ST73 0.0018 O O
ST88 0.0132 O O
ST95 0.0325 O O
ST127 0.1032 O O
ST131 0.3689 0.0001  0.01
ST405 0.0608 O O
a P values (by Fisher’s exact test) are shown only where P  0.05. Bold indicates positive
correlation.
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such as tyrosine arylamidase, L-lactate alkalinization, phospha-
tase, and succinate alkalinization (P  0.005) (Table 5).
DISCUSSION
UPEC bacteria have long been recognized as distinct clones of E.
coli, which exhibit specific characteristics, such as virulence-asso-
ciated traits, distinctive O antigens, selected genotypes, and mul-
tidrug resistance phenotypes (31). This is the first report of meta-
bolic profiling being used to describe the globally disseminated
ST131 clone. The isolates examined were collected at time points 2
years apart and represent UPEC from community- and hospital-
associated infections in patients living in rural and urban areas.
In our collection, UPEC isolates showed biochemical pro-
files similar to those of the general E. coli population with one
exception: -galactosidase was observed in 69% of UPEC iso-
lates compared to 99% of the general E. coli population, as
reported by other groups (5, 6, 17). The reason for the discrep-
ancy in the relatively low incidences of -galactosidase among
UPEC reported in the current study is not clear. However, the
low pH and low glucose concentration of urine could present a
different environmental selective pressure regulating meta-
bolic pathway expression (19).
Some inferences could also be drawn regarding the correlation
between biochemical tests and STs. Although production of orni-
thine decarboxylase and assimilation of sucrose appeared to be
key characteristic in many successful STs, ST131 showed signifi-
cant correlations with three types of metabolic reactions: pepti-
dase (proline arylamidase), decarboxylase (ornithine decarboxyl-
ase), and alkalinization (L-lactate). Among ST131 isolates, the
O25b-CTX-M-15 isolates showed a significant correlation with
FIG 2 Biotype profiling of ST131 isolates: cluster analysis based on metabolic profiles.
FIG 3 Distribution of metabolic profiles of UPEC isolates. ST131 isolates displayed at the left side of the x axis (left of the black line crossing the x axis) were
predominantly susceptible, and those on the right side were resistant (as projected earlier by cluster analysis).
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two other metabolic reactions, tyrosine arylamidase and succinate
alkalinization. Proline and tyrosine arylamidase are specific pep-
tidase enzymes that hydrolyze proline- and tyrosine-rich proteins
(7). Similarly, ornithine decarboxylase is also involved in protein
metabolism.
During growth in human urine, E. coli scavenges amino acids
and peptides, and disruption of peptide import in UPEC signifi-
cantly compromises fitness, suggesting that short peptides taken
up by UPEC are degraded to amino acids and catabolized as in-
termediates for the tricarboxylic acid (TCA) cycle and a substrate
for the gluconeogenesis pathway (1). The other metabolic reac-
tions, such as alkalinization of lactate and succinate, observed with
an elevated incidence could be related to bacterial efforts to relieve
acid stress generated by amino acid metabolism.
We suggest that the high metabolic capacity of ST131 com-
pared to that of other STs allows isolates to compensate for their
relatively low virulence capacity and explains the apparent viru-
lence reported for members of ST131 (8). In contrast, ST127
showed the lowest metabolic capacity, but we have previously
shown that members of this clone have a high virulence potential
(8). The association of clonal groups with specific biochemical
profiles was previously reported for the O157:H7 clone (17) and
the O15:K52:H1 and O25:H4-ST131 clones (4) using API 20E
tests, though we cannot compare our data with the findings of
these studies.
Although no significant association was observed between the
Bio and AST scores in the entire UPEC collection, reexamining the
correlation at the ST level revealed an appreciable positive corre-
lation between metabolic scores and the antibiotic resistance
scores of members of the ST131 clone. Cluster analysis based on
biochemical profiles demonstrated that more than half of the
ST131 isolates shared 70% similarity, forming a single large cluster
that was also characterized by multiple antibiotic resistances,
compared to the rest of the ST131 isolates. This suggests ongoing
subclonal variation and spread of ST131 in the Northwest region
of England.
Several factors may play a role in the success of the ST131 clone;
in 2010, Peirano and Pitout suggested a combination of a phylo-
genetic group B2 background with certain virulence factors and
fluoroquinolone resistance as important factors in the success of
the ST131 clone in causing UTI, whereas the acquisition of CTX-
M-15-carrying plasmids has facilitated the rapid global spread of
the clone (23). Lavigne and colleagues recently suggested that
members of the ST131 clone may represent pathogens with an
optimal balance of limited virulence and antibiotic resistance
(15). Johnson suggested that undefined phylogenetic group B2-
associated factors provide fitness advantages to ST131, indepen-
dent of its virulence traits (11). Recent draft genome sequence
determination for ST131 strain EC958 revealed that the chromo-
somal backbone is most similar to that of the commensal E. coli
O150:H5 strain SE15 (28, 29). SE15 is a B2 strain lacking several
important genomic islands and prophage elements seen in EC958.
The similarity between EC958 and a commensal strain supports
our suggestion that metabolic potential is important for the fitness
of ST131 strains with respect to gut colonization. Previous reports
have also highlighted high levels of intestinal carriage of ST131,
indicating fitness for this environment (18, 25, 30). In a similar
manner, Roos et al. attributed the ability of ABU isolates to be-
come established in the human bladder to their metabolic fitness
(26).
We suggest that further investigation of the metabolic poten-
tial of ST131 isolates, using additional phenotypic assays and ge-
nome sequence determination, will provide new perspectives in
understanding the success of this and other clones (16). It may
also be relevant to examine the metabolic potential of ST131 iso-
lates from other infection sites and non-UPEC E. coli to investigate
the specificity of the profiles identified in the current study.
The high metabolic potential may facilitate adaptation of
strains to different host environments, taking advantage of avail-
able nutrients present in the gut or in urine, such as amino acids
and small peptides, promoting colonization and increasing patho-
genic potential (16). In a diagnostic sense, it may also be possible
to exploit specific metabolic traits in the development of differen-
tial media for recovery and presumptive identification of ST131
isolates.
In conclusion, this study determined the metabolic capacity of
members of successful STs among a well-defined UPEC popula-
tion. Several correlations were observed between the successful
STs and key traits, and these patterns could help to explain why
isolates from certain STs, including ST131, are successful extrain-
testinal pathogenic E. coli clones.
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